Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Cash from Operations (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Cash from Operations for 7 consecutive years, with 11551000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 1409.93% to 11551000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10524000.0 through Dec 2025, up 986.07% year-over-year, with the annual reading at 10524000.0 for FY2025, 986.07% up from the prior year.
  • Cash from Operations hit 11551000.0 in Q4 2025 for Eton Pharmaceuticals, down from 12026000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 12026000.0 in Q3 2025 to a low of 11551000.0 in Q4 2025.
  • Historically, Cash from Operations has averaged 920400.0 across 5 years, with a median of 1048000.0 in 2022.
  • Biggest five-year swings in Cash from Operations: surged 766.94% in 2022 and later plummeted 1409.93% in 2025.
  • Year by year, Cash from Operations stood at 5117000.0 in 2021, then soared by 155.5% to 2840000.0 in 2022, then plummeted by 86.37% to 387000.0 in 2023, then plummeted by 297.67% to 765000.0 in 2024, then tumbled by 1409.93% to 11551000.0 in 2025.
  • Business Quant data shows Cash from Operations for ETON at 11551000.0 in Q4 2025, 12026000.0 in Q3 2025, and 7959000.0 in Q2 2025.